SpicyIP Weekly Review (August 23 – 29)
SpicyIP
AUGUST 30, 2021
Topical Highlight. Kedar concludes that the Court set a much-needed precedent, by settling that even a medical necessity induced by COVID cannot be a free-pass for the pharma-companies to blatantly infringe IP rights and later play victim by justifying their act under the pretext of public emergency. Sun Pharma v. Cipla Ltd. ,
105 
Let's personalize your content